Functional Reversion of Antigen-Specific CD8+ T Cells from Patients with Hodgkin Lymphoma following In Vitro Stimulation with Recombinant Polyepitope
Corey Smith(QIMR Berghofer Medical Research Institute), Rajiv Khanna(QIMR Berghofer Medical Research Institute), Judy Tellam(QIMR Berghofer Medical Research Institute), Paula Marlton(The University of Queensland), Eleanore Lambley(The University of Melbourne), John F. Seymour(The Royal Melbourne Hospital), Natasha Webb(QIMR Berghofer Medical Research Institute), Leanne Cooper(QIMR Berghofer Medical Research Institute), Michael Rist(QIMR Berghofer Medical Research Institute), Melinda Burgess(QIMR Berghofer Medical Research Institute), Maher K. Gandhi(Translational Research Institute)
Cited by 62
Related Papers
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
|Nature Medicine|2013|3k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k